36 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
and their impact on Adaptimmune’s and TCR2’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials
425
TCRR
Tcr2 Therapeutics Inc
30 May 23
Business combination disclosure
4:21pm
health crises and their impact on Adaptimmune’s and TCR2’s respective businesses, operations, supply chain, patient enrollment and retention
8-K
ADAP
Adaptimmune Therapeutics Plc
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
, operations, supply chain, patient enrollment and retention, preclinical and clinical trials, strategy, goals and anticipated milestones. While the foregoing
425
4j887zjy bss8c9q
22 May 23
Business combination disclosure
7:01am
8-K
s98p6j1sn
22 May 23
Other Events
6:59am
8-K
EX-99.1
kjvmabmlb 5biyqb
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am